What the Gyneos® women’s health review covers
This peer-reviewed review, published in Biomedicines, provides a comprehensive scientific framework connecting insulin signaling, hormonal balance, and metabolic health across the female life course. The article highlights the role of Gyneos®, Advenion Nutrition’s standardized D-chiro-inositol ingredient, as a central contributor to healthy insulin signaling, ovarian function, and systemic metabolic balance.
The review discusses how healthy inositol metabolism is relevant across key female life stages — from reproductive years through the menopausal transition and healthy cognitive aging. By supporting insulin sensitivity and hormonal balance through the PI3K/Akt pathway, Gyneos® is presented as a foundational ingredient for women’s reproductive wellness, metabolic resilience, and healthy aging.
This work supports the scientific rationale for Gyneos® — a standardized, traceable source of D-chiro-inositol — as a women-specific metabolic and hormonal modulator that supports overall physiological balance, rather than a symptom-targeted ingredient. By framing the specific Gyneos® ingredient within the broader science of inositol metabolism, the review reinforces the value of standardization and analytical control.
This article is a scientific review intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Gyneos® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease, including polycystic ovary syndrome.